Pharma & HealthcareTop Companies
Pharma & Healthcare

Top CDSS Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

Industry

Pharma & Healthcare

Published

Feb 2026

Share:

Pharma & Healthcare

Top CDSS Market Companies - Rankings, Profiles, Market Share, SWOT & Strategic Outlook

$3,590

Choose License Type

Only one user can use this report

Additional users can access this report

You can share within your company

Company Contents

Quick Facts & Snapshot

2025 Market Size (Global CDSS)
US$ 1.90 Billion
2026 Forecast Market Size
US$ 2.06 Billion
2032 Forecast Market Size
US$ 3.40 Billion
CAGR (2025-2032)
8.60%

Summary

The global Clinical Decision Support Systems (CDSS) market is entering a scale-up phase, with value projected at US$ 1.90 Billion in 2025 and rising to US$ 3.40 Billion by 2032, at an 8.60% CAGR. Safety, workflow efficiency, and data-driven care are propelling adoption, while leading CDSS market companies consolidate share through analytics, EHR integration, and AI-enabled clinical content.

2025 Revenue of Top CDSS Suppliers
ReportMines Logo

Source: Secondary Information and ReportMines Research Team - 2026

Ranking Methodology

Rankings of CDSS market companies in this analysis combine quantitative performance with qualitative assessment. Core inputs include 2025 CDSS-specific revenue, multi-year growth trajectory, win rate in major hospital and payer procurements, and installed base across care settings. We further score technology differentiation, breadth of clinical content, interoperability with EHR and health information exchanges, and AI / machine-learning maturity. Service coverage, including 24/7 support, localization, and professional services depth, is evaluated alongside the ability to manage long-term subscription and maintenance contracts. Each company receives a composite score across market presence, innovation, execution capability, and ecosystem partnerships. Scores are normalized to minimize regional bias, using public filings, validated primary interviews, third-party benchmarks, and conservative modeling where data is undisclosed.

Top 10 Companies in CDSS

1
Epic Systems Corporation
North America, Western Europe, Middle East
Verona, USA
US$ 520.00 Million (estimated)
Integrated EHR-embedded CDSS, medication safety, order sets, and population health analytics
Expanded AI-driven BestPractice Advisories, deeper payer-integration, and cloud-hosted community hospital offerings
2
Oracle Health (Cerner)
North America, Europe, Middle East, Asia Pacific
Kansas City, USA
US$ 430.00 Million (estimated)
Enterprise clinical decision support, medication management, condition-specific pathways
Accelerating cloud migration, unified data platform, and embedded generative AI recommendations
3
Wolters Kluwer Health (UpToDate & Medi-Span)
North America, Europe, Asia Pacific, Latin America
Alphen aan den Rijn, Netherlands
US$ 360.00 Million (estimated)
Evidence-based reference CDS, drug databases, clinical pathways, and embedded alerts
Expanding AI-augmented UpToDate content, local-language editions, and EHR-agnostic API integrations
4
IBM Watson Health (Merative)
North America, Europe, selected Asia Pacific markets
Ann Arbor, USA
US$ 210.00 Million (estimated)
AI-driven oncology and imaging decision support, risk stratification, and clinical analytics
Refocusing portfolio on high-value oncology and imaging workflows, with payor-provider collaborative models
5
Philips Healthcare
Europe, North America, Asia Pacific
Amsterdam, Netherlands
US$ 185.00 Million (estimated)
Critical care, imaging, cardiology, and remote monitoring decision support
Integrating CDSS across enterprise monitoring platforms and scaling cloud-based acute virtual care
6
Change Healthcare (Optum Insight)
North America, selective global imaging networks
Nashville, USA
US$ 155.00 Million (estimated)
Clinical decision support for imaging, utilization management, and payer-provider workflows
Leveraging Optum data assets for real-time utilization and evidence-based authorization tools
7
Elsevier Health
Global academic medical centers and teaching hospitals
Amsterdam, Netherlands
US$ 140.00 Million (estimated)
Clinical reference, order sets, care plans, and education-linked CDSS
Linking education content with point-of-care support, strengthening EHR integration toolkits
8
Siemens Healthineers
Europe, North America, China, Middle East
Erlangen, Germany
US$ 130.00 Million (estimated)
Imaging and lab decision support, radiology workflow orchestration, AI-enabled diagnostics
Expanding AI radiology decision support marketplace and integrating lab CDSS into enterprise diagnostics
9
Allscripts (Altera Digital Health)
North America, Middle East, Australia
Chicago, USA
US$ 115.00 Million (estimated)
Ambulatory and community hospital EHR CDSS, medication and chronic disease management
Focusing on modular CDSS enhancements and cloud-hosted ambulatory offerings
10
Athenahealth
United States, early expansion to Canada and UK
Watertown, USA
US$ 95.00 Million (estimated)
Cloud-native ambulatory CDSS, quality reporting, and population health rules
Scaling rules-based and AI-driven prompts across its ambulatory cloud network

Source: Secondary Information and ReportMines Research Team - 2026

Detailed Company Profiles

1

Epic Systems Corporation

Epic is a dominant EHR vendor whose embedded CDSS engines drive medication safety, order optimization, and population health at scale.

Key Financials: 2025 CDSS revenue US$ 520.00 Million; estimated CDSS segment CAGR 9.20% through 2032.
Flagship Products: Epic BestPractice Advisories, EpicCare Clinical Pathways, Cognitive Computing Alerts
2025-2026 Actions: Investing heavily in AI-based guidance, interoperability with external data sources, and integrated payer decision support modules.
Three-line SWOT: Deep EHR integration and large installed base; Perceived as costly and complex for smaller providers; Opportunity—global EHR modernization programs in Europe and Middle East.
Notable Customers: Kaiser Permanente, Cleveland Clinic, NHS Trusts
2

Oracle Health (Cerner)

Oracle Health delivers enterprise-grade CDSS integrated with Millennium EHR, targeting large health systems and government programs worldwide.

Key Financials: 2025 CDSS revenue US$ 430.00 Million; operating margin in health software estimated at 18.50%.
Flagship Products: Cerner Millennium CDS, HealtheIntent, PowerChart Decision Support
2025-2026 Actions: Unifying clinical and financial datasets on Oracle Cloud and rolling out generative AI clinical summarization tools.
Three-line SWOT: Strong global footprint in hospitals; Integration complexity during Oracle platform transition; Opportunity—cloud migration and analytics cross-sell into existing Cerner base.
Notable Customers: US Department of Veterans Affairs, NHS England sites, Emirates Health Services
3

Wolters Kluwer Health (UpToDate & Medi-Span)

Wolters Kluwer provides evidence-based CDSS content and drug data, integrated into EHRs, pharmacy systems, and payer workflows worldwide.

Key Financials: 2025 CDSS revenue US$ 360.00 Million; R&D and content investment approximately 11.80% of segment revenue.
Flagship Products: UpToDate, Medi-Span Drug Data, UpToDate Pathways
2025-2026 Actions: Expanding real-time clinical pathways, adding local guidelines, and embedding AI-based search in key markets.
Three-line SWOT: Highly trusted clinical content; Limited ownership of core EHR workflow; Opportunity—API-first integration with multiple EHR and telehealth platforms globally.
Notable Customers: Mayo Clinic, Singapore Health Services, Brazil leading teaching hospitals
4

IBM Watson Health (Merative)

Merative focuses its CDSS portfolio on oncology, imaging, and population analytics, leveraging AI and large curated datasets.

Key Financials: 2025 CDSS revenue US$ 210.00 Million; analytics and AI services margin approximately 17.40%.
Flagship Products: Watson for Oncology, Merge PACS Decision Support, Population Health Insights
2025-2026 Actions: Refining AI models, exiting non-core offerings, and partnering with leading cancer centers for co-developed algorithms.
Three-line SWOT: Advanced AI and analytics heritage; Mixed historical perception of Watson in healthcare; Opportunity—value-based care and precision oncology decision support demand.
Notable Customers: Memorial Sloan Kettering collaborators, leading European oncology networks, Asia-Pacific cancer centers
5

Philips Healthcare

Philips integrates CDSS within monitoring, imaging, and cardiology platforms, supporting high-acuity and tele-ICU clinical decisions.

Key Financials: 2025 CDSS revenue US$ 185.00 Million; estimated annual CDSS growth 8.10% aligned with enterprise informatics expansion.
Flagship Products: IntelliSpace Critical Care and Anesthesia, Philips Imaging CDS, eICU Program
2025-2026 Actions: Embedding predictive analytics in monitoring, scaling virtual care programs, and strengthening cloud-native enterprise informatics.
Three-line SWOT: Strong position in acute care workflows; Dependence on capital equipment cycles; Opportunity—virtual wards and remote monitoring expansion needing embedded CDSS.
Notable Customers: US multi-hospital systems, UK NHS ICUs, large academic centers in Germany and Japan
6

Change Healthcare (Optum Insight)

Change Healthcare, now under Optum, delivers CDSS that bridges clinical and payer workflows, emphasizing imaging and utilization management.

Key Financials: 2025 CDSS revenue US$ 155.00 Million; utilization management CDSS growth estimated at 9.80% annually.
Flagship Products: Clinical Decision Support Mechanism (CDSM), Imaging CDS, InterQual-based solutions
2025-2026 Actions: Integrating with Optum data lake, enhancing real-time prior authorization and evidence-based utilization tools.
Three-line SWOT: Rich claims and clinical datasets; Regulatory scrutiny around payer-provider alignment; Opportunity—US value-based care and CMS-compliant imaging CDS mandates.
Notable Customers: US commercial payers, radiology groups, integrated delivery networks
7

Elsevier Health

Elsevier offers content-centric CDSS, linking clinical reference, care plans, and order sets to drive standardized, evidence-based practice.

Key Financials: 2025 CDSS revenue US$ 140.00 Million; investment in digital platforms roughly 10.60% of revenue.
Flagship Products: ClinicalKey, Order Sets, Elsevier Care Planning
2025-2026 Actions: Enhancing interoperability, building SMART-on-FHIR apps, and bundling education with point-of-care decision tools.
Three-line SWOT: Strong academic presence and content depth; Less control over transactional EHR layer; Opportunity—emerging markets and education-health system convergence.
Notable Customers: Top US teaching hospitals, European university hospitals, large systems in the Middle East
8

Siemens Healthineers

Siemens Healthineers embeds CDSS into imaging and diagnostics ecosystems, enabling radiology, cardiology, and lab decision support.

Key Financials: 2025 CDSS revenue US$ 130.00 Million; diagnostics IT and AI solutions growth about 9.00% annually.
Flagship Products: AI-Rad Companion, Syngo Virtual Cockpit, Atellica Diagnostics IT CDS
2025-2026 Actions: Scaling AI marketplaces, integrating lab CDSS with enterprise imaging, and partnering with university hospitals.
Three-line SWOT: Deep diagnostics portfolio and AI pipeline; Fragmented software user experience historically; Opportunity—enterprise diagnostics strategies and radiologist workforce shortages.
Notable Customers: Charité Berlin, large US health systems, major Chinese tertiary hospitals
9

Allscripts (Altera Digital Health)

Altera focuses on modular EHR and CDSS for community hospitals and ambulatory providers, emphasizing openness and flexibility.

Key Financials: 2025 CDSS revenue US$ 115.00 Million; CDSS cloud subscriptions growing roughly 7.90% per year.
Flagship Products: Sunrise Clinical Manager CDS, TouchWorks CDS, Altera Analytics
2025-2026 Actions: Rebranding under Altera, modernizing user interface, and expanding cloud-based ambulatory CDSS features.
Three-line SWOT: Configurable, open platforms; Smaller scale versus top-tier EHR vendors; Opportunity—mid-market hospitals seeking cost-effective CDSS modernization.
Notable Customers: US regional health systems, Saudi Arabian hospitals, Australian provider networks
10

Athenahealth

Athenahealth delivers cloud-native EHR and CDSS for ambulatory providers, leveraging network data for real-time best-practice prompts.

Key Financials: 2025 CDSS revenue US$ 95.00 Million; ambulatory CDSS network effects driving 10.10% annual growth.
Flagship Products: AthenaOne CDS, Population Health Rules Engine, Quality Management CDS
2025-2026 Actions: Enhancing AI triage suggestions, automating quality reporting, and piloting chronic disease pathways in primary care.
Three-line SWOT: Highly scalable cloud architecture and data network; Limited acute-care presence; Opportunity—US outpatient growth and telehealth-integrated CDSS expansion.
Notable Customers: Independent US physician groups, Federally Qualified Health Centers, multi-specialty ambulatory networks

SWOT Leaders

Epic Systems Corporation

SWOT Snapshot

SWOT
Strengths

Massive EHR installed base, tightly embedded CDSS, strong brand trust, and deep integration with hospital workflows globally.

Weaknesses

High implementation cost, lengthy deployment timelines, limited appeal for small practices, and dependence on Epic-centric ecosystems.

Opportunities

International EHR replacements, AI-augmented decision support, and payer-provider alignment for real-time prior-authorization guidance.

Threats

Intensifying competition from cloud-native vendors, regulatory shifts on information blocking, and hospital budget pressures delaying upgrades.

Oracle Health (Cerner)

SWOT Snapshot

SWOT
Strengths

Broad global presence, strong government and large-system footprint, and integrated data platform under Oracle Cloud infrastructure.

Weaknesses

Platform transition complexity, legacy on-premise deployments, and potential customer fatigue around consolidation and rebranding.

Opportunities

Cloud migrations, analytics-driven CDSS, and leveraging Oracle enterprise relationships for cross-industry healthcare expansion.

Threats

Rival EHR platforms investing in advanced CDSS, data sovereignty concerns, and procurement risk in large government programs.

Wolters Kluwer Health (UpToDate & Medi-Span)

SWOT Snapshot

SWOT
Strengths

Highly trusted clinical evidence, global brand recognition, and broad integrations with multiple EHR, pharmacy, and payer systems.

Weaknesses

Limited ownership of core transactional workflows, reliance on integration partners, and subscription sensitivity in cost-constrained markets.

Opportunities

Expanding local-language content, API-first CDSS into telehealth, and advanced analytics for guideline adherence measurement.

Threats

Free or low-cost alternatives, emerging AI-native content tools, and hospital consolidation squeezing content budgets.

CDSS Market Regional Competitive Landscape

North America remains the largest CDSS market, underpinned by mature EHR adoption, strong regulatory impetus, and value-based care incentives. Epic Systems Corporation and Oracle Health dominate large health systems, while Athenahealth and Allscripts target ambulatory and community hospitals. Payers increasingly demand CDSS integration to support utilization management and quality reporting.

In Western Europe, demand centers on interoperability, guideline adherence, and language-localized decision support. Wolters Kluwer Health and Elsevier Health are entrenched content leaders, while Epic Systems Corporation and Philips Healthcare expand through major national EHR and monitoring contracts. EU data-protection rules favor CDSS market companies that demonstrate robust security and transparent AI governance.

Asia Pacific shows the fastest growth, driven by hospital digitalization in China, India, and Southeast Asia. Siemens Healthineers and Philips Healthcare leverage strong imaging and monitoring installed bases, integrating CDSS into diagnostics workflows. Global CDSS market companies increasingly partner with local EHR vendors to navigate localization, price sensitivity, and varied regulatory requirements.

In the Middle East, large government-backed modernization programs prioritize integrated platforms covering EHR, CDSS, and revenue-cycle capabilities. Oracle Health and Epic Systems Corporation compete for flagship national projects, while Allscripts and regional players address mid-sized providers. Procurement emphasizes Arabic-language content, advanced analytics, and long-term managed-service models.

Latin America remains relatively underpenetrated but attractive for content-centric and cloud-based CDSS. Wolters Kluwer Health and Elsevier Health capitalize on strong academic networks, offering evidence-based tools that integrate with domestic EHR systems. Economic volatility encourages subscription-based, modular solutions from CDSS market companies rather than large, upfront capital projects.

CDSS Market Emerging Challengers & Disruptive Start-Ups

Emerging Challengers & Disruptive Start-Ups

MedReasonAI
Disruptor
USA

Develops explainable AI CDSS that generates human-readable rationales for recommendations, targeting community hospitals needing transparent clinical algorithms.

ClinFlow Insights
Disruptor
Germany

Offers cloud-native, FHIR-first CDSS microservices that plug into any certified EHR, optimizing care pathways and resource utilization in real time.

RxGuard Analytics
Disruptor
India

Focuses on medication safety CDSS for high-volume hospitals, combining prescription analytics with localized formulary intelligence and pharmacovigilance alerts.

Horizon Triage Systems
Disruptor
United Kingdom

Provides ED triage and virtual-urgent-care CDSS using AI-driven risk scoring, integrated with telehealth platforms and nurse call centers.

NeuroVista CDS
Disruptor
Canada

Specializes in neurology-focused CDSS for stroke and epilepsy centers, integrating imaging, EEG, and clinical data into real-time treatment guidance.

CDSS Market Future Outlook & Key Success Factors (2026-2032)

From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning CDSS market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.

Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards CDSSmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.

Frequently Asked Questions

Find answers to common questions about this company report.